Earnings History Data for Sonoma Pharmaceuticals, Inc. (SNOA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-08-2024 | PM | SNOA | Sonoma Pharmaceuticals, Inc. | 5.63 | -0.07 | 0.00 | -0.29 | Sonoma Pharmaceuticals reports Q1 results [8/9/2024 2:12 AM] |
0.2467 | -0.06 (-20.08%) |
0.29 | -0.02 (-6.19%) |
0.12 - 1.06 | 1,622,969 | 1,210,000 | 26,920 | ||
| 13-11-2023 | PM | SNOA | Sonoma Pharmaceuticals, Inc. | 0.85 | -0.20 | 0.00 | -0.19 | Sonoma Pharmaceuticals GAAP EPS of -$0.29 misses by $0.05, revenue of $2.73M misses by $0.75M [11/14/2023 1:37 AM] |
0.1556 | 0.0 (-0.64%) |
0.16 | 0.0 (3.19%) |
0.12 - 2.68 | 108,300 | 520,000 | 2,331 | ||